Pharmacokinetic and Pharmacodynamic Bio-Similarity of ADL-018 to Innovator Omalizumab: A Randomized Study in Healthy Adults.

Soitawala S, Prajapati H, Mehta H, Singh PK

Open source

DOI
10.1002/cpdd.70098
Published
2026 Sep
Container
Clinical pharmacology in drug development
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cpdd.70098,
  title = {Pharmacokinetic and Pharmacodynamic Bio-Similarity of ADL-018 to Innovator Omalizumab: A Randomized Study in Healthy Adults.},
  author = {Soitawala S and Prajapati H and Mehta H and Singh PK},
  year = {2026},
  journal = {Clinical pharmacology in drug development},
  doi = {10.1002/cpdd.70098},
  url = {https://doi.org/10.1002/cpdd.70098}
}

RIS

TY  - JOUR
TI  - Pharmacokinetic and Pharmacodynamic Bio-Similarity of ADL-018 to Innovator Omalizumab: A Randomized Study in Healthy Adults.
AU  - Soitawala S
AU  - Prajapati H
AU  - Mehta H
AU  - Singh PK
PY  - 2026
JO  - Clinical pharmacology in drug development
DO  - 10.1002/cpdd.70098
UR  - https://doi.org/10.1002/cpdd.70098
ER  - 

APA

S, S., H, P., H, M., & PK, S. (2026). Pharmacokinetic and Pharmacodynamic Bio-Similarity of ADL-018 to Innovator Omalizumab: A Randomized Study in Healthy Adults.. Clinical pharmacology in drug development. https://doi.org/10.1002/cpdd.70098

Source records